Study Report

Basic Info
Reference |
Okumura, T., 2010 PMID: 20016223
|
Citation |
Okumura, T., T. Kishi, et al. (2010). "Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population." Neuropsychobiology 61(2): 57-63.
|
Disease Type |
Bipolar Disorder & Major Depressive Disorder |
Study Design |
case-control |
Study Type |
Candidate-gene association study |
Sample Size |
325 MDD patients, 154 BP patients and 807 controls |
SNP/Region/Marker Size |
1 SNP |
Predominant Ethnicity |
Mongloid |
Population |
Japanese |
Gender |
160 males and 165 females for MDD patients, 80 males and 74 females for BP patients, 354 males and 453 females for controls. |
Age Group |
adult
:
mean age(SD) = 47.3(14.9) years for MDD patients, 47.9(14.2) years for bipolar disorder patients and 37.2(15.9) years for controls.
|

Detail Info
Sample Diagnosis |
DSM-IV |
Sample Status |
117 (58 males and 59 females; mean age (standard deviation) = 44.8 (16.7) years) MDD patients were treated with fluvoxamine. Patients with insomnia and severe anxiety were prescribed benzodiazepine drugs, but no other psychotropic drugs were permitted during the study. |
Technique |
We used TaqMan assays (Applied Biosystems, Foster City, Calif., USA) for all single nucleotide polymorphisms (SNPs). |
Statistical Method |
Genotype deviation from the Hardy-Weinberg equilibrium (HWE) was evaluated by the X2 test. Marker-trait association analysis was used to evaluate the allele- and genotype-wise association with the X2 test. Gender, age at the time of recruitment, fluvoxamine dose at 8 weeks and SIGH-D total score at baseline were covariates used in the analysis to better model the effect of genotype on the percent decrease in the SIGH-D score from baseline to the end of the period of observation. Power calculation was performed using the genetic power calculator. |
Result Summary |
We did not detect a significant association between NOS1 and MDD, BP or the fluvoxamine therapeutic response in MDD in allele/genotype-wise analysis |

Genetic factors reported by this study for BD

Genetic factors reported by this study for SZ and/or MDD